Glen Eagle Advisors, LLC Astrazeneca PLC Transaction History

Glen Eagle Advisors, LLC

$546 Billion
Q2 2024

A detailed history of Glen Eagle Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 574 shares of AZN stock, worth $47,682. This represents 0.01% of its overall portfolio holdings.

Number of Shares

574

Previous 850 32.47%

Holding current value

$47,682

Previous $29.7 Million 50.7%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $18,439 - $22,309	-276 Reduced 32.47%	574 $44.8 Million
Q1 2024 Jul 03, 2024	BUY	$61.03 - $69.57 $16,295 - $18,575	267 New	267 $18.1 Million
Q4 2023 Aug 13, 2024	SELL	$61.89 - $69.28 $3,094 - $3,464	-50 Reduced 15.77%	267 $18 Million
Q3 2023 Aug 13, 2024	BUY	$64.85 - $71.7 $1,361 - $1,505	21 Added 7.09%	317 $21.5 Million
Q2 2023 Aug 13, 2024	BUY	$69.91 - $75.81 $69 - $75	1 Added 0.34%	296 $21.1 Million
Q1 2023 Aug 13, 2024	SELL	$63.15 - $71.6 $757 - $859	-12 Reduced 3.91%	295 $20.5 Million
Q4 2022 Aug 13, 2024	BUY	$54.21 - $70.44 $9,595 - $12,467	177 Added 136.15%	307 $20.8 Million
Q3 2022 Aug 13, 2024	BUY	$53.02 - $135.75 $2,491 - $6,380	47 Added 56.63%	130 $7.13 Million
Q2 2022 Aug 13, 2024	SELL	$59.26 - $71.14 $888 - $1,067	-15 Reduced 15.31%	83 $5.48 Million
Q4 2021 Aug 13, 2024	SELL	$54.02 - $63.83 $24,579 - $29,042	-455 Reduced 82.28%	98 $5.71 Million
Q1 2021 Aug 13, 2024	BUY	$47.16 - $54.44 $12,733 - $14,698	270 Added 95.41%	553 $27.5 Million
Q4 2020 Aug 13, 2024	BUY	$48.52 - $58.02 $776 - $928	16 Added 5.99%	283 $14.1 Million
Q3 2020 Aug 13, 2024	BUY	$53.07 - $61.1 $2,653 - $3,055	50 Added 25.0%	250 $13.7 Million
Q2 2019 Aug 13, 2024	SELL	$37.28 - $41.68 $24,232 - $27,092	-650 Reduced 76.47%	200 $8.26 Million
Q1 2019 Aug 13, 2024	BUY	$35.49 - $43.02 $20,690 - $25,080	583 Added 218.35%	850 $34.4 Million
Q1 2018 Aug 14, 2024	BUY	$32.97 - $36.63 $19,221 - $21,355	583 Added 218.35%	850 $29.7 Million
Q3 2017 Aug 13, 2024	BUY	$28.96 - $34.0 $16,883 - $19,822	583 Added 218.35%	850 $28.8 Million
Q4 2016 Aug 12, 2024	BUY	N/A	733	1,000 $27.3 Million

Others Institutions Holding AZN

# of Institutions

1,331

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $257B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Account

Glen Eagle Advisors, LLC Astrazeneca PLC Transaction History